PERSOWN
Overview
PERSOWN is a biotechnology company focused on revolutionizing the accessibility and usage of health data to enhance healthcare outcomes globally. Founded in 2020, PERSOWN is headquartered in Jacksonville, Florida. The company was established with the goal of providing low-cost, point-of-care diagnostic solutions using advanced technology, including AI and blockchain, to enable secure and immediate access to healthcare data. With significant advancements in AI and health analytics, PERSOWN aims to transform healthcare practices by improving data interoperability among different healthcare systems.
Recent Developments
- 2024: PERSOWN announced a collaboration with SAS, a global leader in healthcare analytics, to expand its data analytics capabilities. This move aims to enhance the predictive analysis of health data, focusing on sepsis management and other critical health conditions.
- 2024: Successfully raised an additional $120,000 in an early-stage venture capital funding round, reflecting continued investor confidence in its technologies and business model.
- 2023: PERSOWN introduced a new AI-powered health analytics tool that integrates with electronic health systems to improve diagnosis and patient outcomes by predicting disease trends.
- During 2023, PERSOWN expanded its employee base by 20%, underscoring operational growth in response to increasing demand for its diagnostic solutions.
- 2022: The company unveiled a smartphone app designed for instant point-of-care diagnostics, showcasing its commitment to making healthcare more accessible, especially in underserved regions.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2020 |
| Headquarters | Jacksonville, FL, USA |
| Founders | Not publicly disclosed |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Early-stage venture capitalists |
| Industry | Biotechnology, Healthcare Technology |
| Number of Employees | Approximately 25 |
Early History
PERSOWN was founded in 2020 with the vision of making advanced healthcare diagnostics available to all, including populations in resource-limited settings. The founding team, noticing the significant gaps in healthcare delivery, particularly the delays and inaccessibility in diagnostics, sought to leverage blockchain and AI technologies to provide comprehensive solutions. Funding from early investors was instrumental in the initial development phase, allowing PERSOWN to create prototypes of their diagnostic tools and establish early partnerships with tech leaders like SAS.
Company Profile and Achievements
PERSOWN is fundamentally transforming how healthcare data is accessed and utilized. The company utilizes AI-driven platforms to analyze vast amounts of health data, improving the early detection of diseases, such as sepsis, which pose a major healthcare challenge globally.
Key milestones:
- 2021: Launched its first AI-powered diagnostic tool that gained significant attention in the healthcare analytics community.
- 2022: Expanded its technological infrastructure to ensure data interoperability across diverse healthcare applications and systems.
- 2023: Partnered with major healthcare bodies to implement its solutions in real-world scenarios, thus validating its practical applications and benefits.
Current Operations and Market Position
PERSOWN operates at the intersection of biotechnology and information technology. Its current business activities focus on enhancing data-driven decision-making in healthcare by providing tools that empower healthcare providers and patients. By leveraging continuous analytics and AI, PERSOWN distinguishes itself from competitors by offering affordable testing solutions that are accessible via smartphones. This not only broadens its market reach but also supports its mission to impact global health positively.
Conclusion
PERSOWN stands out in the biotechnology sector for its dedication to making healthcare diagnostics more accessible and efficient through technological innovation. Its strategic alliances and continuous funding successes underscore the company's potential to reshape healthcare AI and analytics. With a forward-looking approach, PERSOWN is poised to expand its influence across the healthcare industry, ultimately contributing to enhanced healthcare delivery and patient care globally.